Dehradun

DBIPR is situated in separate premises in Dev Bhoomi Campus Dehradun. The Institute offers AICTE & PCI Approved Four Year B.Pharmacy and 2 Year M.Pharmacy(Pharmacology) Courses Affiliated to Uttrakhand Technical University, Dehradun.

Post: Professor/Associate Professor and Asst. Professors

Originally Gujarat based Company presence of 35 years in Pharma formulation having own marketing setup as well as 3rd party/loan licence activity at Gujarat and Dehradun plant.

Post: Assistant Manager- Q.A.

Originally Gujarat based Company presence of 35 years in Pharma formulation having own marketing setup as well as 3rd party/loan licence activity at Gujarat and Dehradun plant.

Post: QC officer

Originally Gujarat based Company presence of 35 years in Pharma formulation having own marketing setup as well as 3rd party/loan licence activity at Gujarat and Dehradun plant.

Post: Officer – QA

Troikaa mainly focuses on Novel Drug Delivery Systems (NDDS). The company firmly believes in providing superior therapeutic benefits by improvising the formulations through Innovative Technologies.
Six patents have been filed in various areas of drug delivery. To handle competition, Troikaa adopted various multifaceted strategies to help stand their ground in the competitive market. Another fact that helps us stand out is their high quality products.

Windlas Biotech Limited is an independent contract manufacturer serving the Indian and international pharmaceutical industry. They are a company of professionally alive, forward looking and committed team members serving the medical fraternity. Their primary focus is to consistently meet the global manufacturing requirements of their customers by providing cost-effective services and delivering quality products efficiently and reliably.

Ajanta Pharma Limited is an emerging, global pharmaceutical company with proven capabilities in the areas of product research, manufacturing & marketing.

Troikaa mainly focuses on Novel Drug Delivery Systems (NDDS). The company firmly believes in providing superior therapeutic benefits by improvising the formulations through Innovative Technologies.
Six patents have been filed in various areas of drug delivery. To handle competition, Troikaa adopted various multifaceted strategies to help stand their ground in the competitive market. Another fact that helps us stand out is their high quality products.

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.